142 related articles for article (PubMed ID: 27926519)
1. Diagnostic and prognostic value of miR-106a in colorectal cancer.
Hao H; Liu L; Zhang D; Wang C; Xia G; Zhong F; Hu X
Oncotarget; 2017 Jan; 8(3):5038-5047. PubMed ID: 27926519
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of microRNA-21 in colorectal cancer: an original study and individual participant data meta-analysis.
Zhang H; Li P; Ju H; Pesta M; Kulda V; Jin W; Cai M; Liu C; Wu H; Xu J; Ye Y; Zhang G; Xu E; Cai J; Lai M; Xia D; Yang J; Wu Y
Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2783-92. PubMed ID: 25178983
[TBL] [Abstract][Full Text] [Related]
3. Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis.
Han S; Zong S; Shi Q; Li H; Liu S; Yang W; Li W; Hou F
EBioMedicine; 2017 Jun; 20():61-69. PubMed ID: 28558958
[TBL] [Abstract][Full Text] [Related]
4. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
5. The clinical role of microRNA-21 as a promising biomarker in the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
Peng Q; Zhang X; Min M; Zou L; Shen P; Zhu Y
Oncotarget; 2017 Jul; 8(27):44893-44909. PubMed ID: 28415652
[TBL] [Abstract][Full Text] [Related]
6. miR-203 as a novel biomarker for the diagnosis and prognosis of colorectal cancer: a systematic review and meta-analysis.
Ye H; Hao H; Wang J; Chen R; Huang Z
Onco Targets Ther; 2017; 10():3685-3696. PubMed ID: 28769572
[TBL] [Abstract][Full Text] [Related]
7. Detection of microRNA-21 expression as a potential screening biomarker for colorectal cancer: a meta-analysis.
Jiang JX; Zhang N; Liu ZM; Wang YY
Asian Pac J Cancer Prev; 2014; 15(18):7583-8. PubMed ID: 25292032
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of MicroRNAs in Stage II Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Sabarimurugan S; Madhav MR; Kumarasamy C; Gupta A; Baxi S; Krishnan S; Jayaraj R
Mol Diagn Ther; 2020 Feb; 24(1):15-30. PubMed ID: 32020560
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of circulating miR-21 for colorectal cancer: a meta-analysis.
Shan L; Ji Q; Cheng G; Xia J; Liu D; Wu C; Zhu B; Ding Y
Cancer Biomark; 2015; 15(1):47-56. PubMed ID: 25524942
[TBL] [Abstract][Full Text] [Related]
10. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
Li C; He X; Zhang L; Li L; Zhao W
BMC Cancer; 2019 Oct; 19(1):957. PubMed ID: 31615475
[TBL] [Abstract][Full Text] [Related]
11. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
[TBL] [Abstract][Full Text] [Related]
12. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Prognostic Value of miR-451 Expression in Colorectal Cancer: A Meta-Analysis.
Amiri-Dashatan N; Koushki M; Ahmadi NA; Ahmadi H; Rezaei Tavirani M
Asian Pac J Cancer Prev; 2024 Jun; 25(6):1903-1910. PubMed ID: 38918650
[TBL] [Abstract][Full Text] [Related]
14. Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer.
Li C; Wang X; Casal I; Wang J; Li P; Zhang W; Xu E; Lai M; Zhang H
J Cell Mol Med; 2016 Aug; 20(8):1420-6. PubMed ID: 26990020
[TBL] [Abstract][Full Text] [Related]
15. The role of circulating microRNAs as novel biomarkers in diagnosing colorectal cancer: a meta-analysis.
Rokkas T; Kothonas F; Rokka A; Koukoulis G; Symvoulakis E
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):819-25. PubMed ID: 25856691
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of neutrophil gelatinase-associated lipocalin (NGAL) in colorectal cancer: a meta-analysis.
Wang Y; Zeng TT
Genet Mol Res; 2014 Feb; 13(3):7102-12. PubMed ID: 24634297
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Prognostic Value of Serum Interleukin-6 in Colorectal Cancer.
Xu J; Ye Y; Zhang H; Szmitkowski M; Mäkinen MJ; Li P; Xia D; Yang J; Wu Y; Wu H
Medicine (Baltimore); 2016 Jan; 95(2):e2502. PubMed ID: 26765465
[TBL] [Abstract][Full Text] [Related]
18. Investigation of microRNA-155 as a serum diagnostic and prognostic biomarker for colorectal cancer.
Lv ZC; Fan YS; Chen HB; Zhao DW
Tumour Biol; 2015 Mar; 36(3):1619-25. PubMed ID: 25528214
[TBL] [Abstract][Full Text] [Related]
19. The accuracy of circulating microRNA-21 in the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Xu F; Xu L; Wang M; An G; Feng G
Colorectal Dis; 2015 May; 17(5):O100-7. PubMed ID: 25683351
[TBL] [Abstract][Full Text] [Related]
20. Biomarker roles identification of miR-106 family for predicting the risk and poor survival of colorectal cancer.
Peng Q; Shen Y; Zhao P; Cheng M; Zhu Y; Xu B
BMC Cancer; 2020 Jun; 20(1):506. PubMed ID: 32493303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
